These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5749368)

  • 1. [Study of the purification of a toxic factor in the urine of schizophrenic subjects].
    Fujita K
    Sapporo Igaku Zasshi; 1968; 33(1):12-21. PubMed ID: 5749368
    [No Abstract]   [Full Text] [Related]  

  • 2. A pink spot in thyrotoxicosis.
    Widelitz M; Feldman W
    Biol Psychiatry; 1971; 3(2):181-4. PubMed ID: 5089913
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychotogenic N,N-Dimethylated indole amines and behavior in schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Recent Adv Biol Psychiatry; 1968; 10():6-15. PubMed ID: 4873523
    [No Abstract]   [Full Text] [Related]  

  • 4. Modifications of paper and thin layer chromatographic methods to increase sensitivity for detecting n-methylated indoleamines in urine.
    Tanimukai H
    J Chromatogr; 1967 Sep; 30(1):155-63. PubMed ID: 6057433
    [No Abstract]   [Full Text] [Related]  

  • 5. Some observations concerning the "pink spot" reacting substances in urine.
    Watt JA; Ashcroft GW; Daly RJ; Smythies JR
    Acta Psychiatr Scand; 1970; 46(4):374-90. PubMed ID: 5502783
    [No Abstract]   [Full Text] [Related]  

  • 6. Identity and significance of some pink spots in schizophrenia and other conditions.
    Perry TL; Hansen S; MacDougall L
    Nature; 1967 Apr; 214(5087):484-5. PubMed ID: 6040612
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)].
    Stanciu E; Csiky K; Rácz E
    Neurol Psihiatr Neurochir; 1971; 16(4):305-12. PubMed ID: 5118389
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of 3,4-dimethoxyphenethylamine from schizophrenic urine by mass spectrometry.
    Creveling CR; Daly JW
    Nature; 1967 Oct; 216(5111):190-1. PubMed ID: 6057236
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological determination of the toxicity of pathological body fluids. V. On the effect of amine fractions from urine extracts of mental and neurological patients].
    CHRIST H; RIEDER HP
    Confin Neurol; 1959; 19():319-28. PubMed ID: 13810061
    [No Abstract]   [Full Text] [Related]  

  • 10. [Microchromatographic determination of 17-ketosteroid fractions in psychasthenic and schizophrenic subjects].
    CAVALCA GG; ROSSINI R
    Riv Patol Nerv Ment; 1955; 76(1):188-94. PubMed ID: 14396207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of biogenic amines in the etiopathogenesis of schizophrenia].
    Dogaru C; Grecu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(3):229-33. PubMed ID: 6239353
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence of toxic factors in urine from schizophrenic subjects.
    FUJITA S; GING NS
    Science; 1961 Nov; 134(3491):1687-8. PubMed ID: 13895753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the presence of bufotenin in the urine of schizophrenic patients].
    Sireix DW; Marini FA
    Rev Sanid Milit Argent; 1967; 66(1):14-21. PubMed ID: 5629061
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of bufotenin in the urine of schizophrenics.
    Fischer E; Spatz H
    Int J Neuropsychiatry; 1967 Jun; 3(3):226-8. PubMed ID: 6034731
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of bufotenin in the urine of schizophrenic patients and normal persons.
    Faurbye A; Pind K
    Nature; 1968 Nov; 220(5166):489. PubMed ID: 5686166
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory and animal studies on the chemistry of bufotenin. Quantitative determination on bufotenin in human urine.
    Spatz H; Sireix DW; Marini FA; Fischer E; Bonhour A; Acebal EM
    Behav Neuropsychiatry; 1969 Aug; 1(5):25-7. PubMed ID: 5398113
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of a characteristic substance in the urine of schizophrenics.
    Mattok GL; O'Reilly PO; Hughes G
    Dis Nerv Syst; 1967 Jun; 28(6):405-6. PubMed ID: 6033180
    [No Abstract]   [Full Text] [Related]  

  • 18. [Paper chromatographic studies on the urine of schizophrenics and healthy subjects before and after DOPA administration].
    LENZ H
    Psychopharmacologia; 1962; 3():146-51. PubMed ID: 14464035
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition and activation of caeruloplasmin by extracts from the urine of schizophrenic patients.
    Barrass BC; Coult DB; Drysdale AC; Marjot DH
    Biochem Pharmacol; 1970 May; 19(5):1675-9. PubMed ID: 5513947
    [No Abstract]   [Full Text] [Related]  

  • 20. [The cold Millon reaction in schizophrenia and patients with schizophrenic traits].
    SANO I
    Folia Psychiatr Neurol Jpn; 1954 Dec; 8(3):218-31. PubMed ID: 14365941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.